Abstract
Atherosclerosis leads to vascular lesions that involve major rearrangements of the vascular proteome, especially of the extracellular matrix (ECM). Using single aortas from ApoE knock out mice, we quantified formation of plaques by single-run, high-resolution mass spectrometry (MS)based proteomics. To probe localization on a proteome-wide scale we employed quantitative detergent solubility profiling. This compartment- and time-resolved resource of atherogenesis comprised 5117 proteins, 182 of which changed their expression status in response to vessel maturation and atherosclerotic plaque development. In the insoluble ECM proteome, 65 proteins significantly changed, including relevant collagens, matrix metalloproteinases and macrophage derived proteins. Among novel factors in atherosclerosis, we identified matrilin-2, the collagen IV crosslinking enzyme peroxidasin as well as the poorly characterized MAM-domain containing 2 (Mamdc2) protein as being up-regulated in the ECM during atherogenesis. Intriguingly, three subunits of the osteoclast specific V-ATPase complex were strongly increased in mature plaques with an enrichment in macrophages thus implying an active de-mineralization function.
| Original language | English |
|---|---|
| Journal | Molecular and Cellular Proteomics |
| Volume | 17 |
| Issue number | 2 |
| Pages (from-to) | 321-334 |
| Number of pages | 14 |
| ISSN | 1535-9476 |
| DOIs | |
| Publication status | Published - 02.2018 |
Funding
* This work was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (e:AtheroSysMed, 01ZX1313A-2014, 01ZX1313F-2014 and 01ZX1313G-2014), the Deutsche Forschungs-gemeinschaft (CRC 1123 [B3] and Munich Cluster for Systems Neurology [SyNergy]), and the FP7/2007–2103 European Union project CVgenes@target (grant agreement No Health-F2-2013-601456). □S This article contains supplemental material. ‖‖ To whom correspondence should be addressed: Department of Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany. Tel.: +49-(0)-89-8578-2557; Fax: +49-(0)-89-8578-2219; E-mail: mmann@ biochem.mpg.de or Institute for Stroke and Dementia Research, Klini-kum der Universität München, Feodor-Lynen-Straße 17, 81377 München, Germany. Tel.: +49-(0)-89-4400-46018; Fax: +49-(0)-89-4400-46010; E-mail: [email protected]. aThese authors contributed equally to this work.
Research Areas and Centers
- Research Area: Medical Genetics